Anterix Inc.ATEXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank28
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P28
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-8.91%
Q3 20258.21%
Q2 20252.85%
Q1 2025-2.77%
Q4 2024-36.94%
Q3 20241.49%
Q2 2024-21.98%
Q1 202481.18%
Q4 20237.93%
Q3 20237.30%
Q2 2023-25.09%
Q1 202352.46%
Q4 2022-4.49%
Q3 2022-10.58%
Q2 202242.89%
Q1 2022-14.11%
Q4 2021-3.98%
Q3 2021-7.28%
Q2 2021-23.44%
Q1 20215.31%
Q4 202025.91%
Q3 202023.35%
Q2 2020-27.64%
Q1 202081.48%
Q4 20199.91%
Q3 2019-19.10%
Q2 201953.47%
Q1 2019-31.65%
Q4 201814.14%
Q3 2018-10.05%
Q2 20189.83%
Q1 2018-2.03%
Q4 2017-5.73%
Q3 201713.77%
Q2 2017-5.15%
Q1 20177.94%
Q4 2016-13.30%
Q3 20168.55%
Q2 201668.34%
Q1 2016-0.24%